Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.003 Å; R factor = 0.024; wR factor = 0.069; data-to-parameter ratio = 12.7.
In the title compound, [Mn(C 2 O 4 )(C 10 H 7 N 3 S)] n , the Mn II cation is chelated by one 2-(1,3-thiazol-4-yl)-1H-benzimidazole ligand and two oxalate anions in a distorted N 2 O 4 octahedral geometry. Two independent oxalate anions are located on individual inversion centers and bridge the Mn II cations into a polymeric chain running along [101] . The thiazole ring is approximately coplanar with the benzimidazole ring system [dihedral angle = 4.19 (9) ]. In the crystal, classical N-HÁ Á ÁO hydrogen bonds and weak C-HÁ Á ÁO hydrogen bonds link the polymeric chains into a threedimensional supramolecular architecture.
Related literature
For applications of thiabendazole compounds, see: Yu et al. (2002) ; Devereux et al. (2004) . For related structures, see: Wisniewski et al. (2001) ; Jean et al. (2002) .
Experimental
Crystal data Mo K radiation = 1.14 mm Hydrogen-bond geometry (Å , ). Data collection: SMART (Bruker, 2007 ); cell refinement: SAINT (Bruker, 2007) ; data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL.
Comment
Thiabendazole aroused considerable interest in biology and medicine due to its antiproliferative activities. It is an antimicrobial drug belonging to the benzimidazole derivative, and has exhibited wide applications in human and veterinary medicine (Jean et al., 2002; Devereux et al., 2004) .
As part of our studies of the synthesis and characterization of these compounds, we report here the synthesis and crystal structure of [Mn(C 2 O 4 )(thiabendazole)] n . In this work, the structure of the complex is formed by infinite one-dimensional (Wisniewski et al., 2001; Yu et al., 2002) .
Experimental
A solution of thiabendazole (0.2023 g, 1 mmol) in 5 ml DMF was added dropwise with stirring at room temperature to a solution of Mn(Cl) 2 .4H 2 O (0.1976 g, 1 mmol), H 2 C 2 O 4 (0.0411 g, 0.5 mmol) in the mixture of 12.5 ml water and 5 ml methanol. Then an aqueous solution of sodium hydroxide was added dropwise with stirring to adjust the pH value of the solution being 6.5. The resulting mixture was sealed in a 25 mL Teflon-lined stainless reactor, kept under autogenous pressure at 423 K for 72 h, and then slowly cooled to room temperature at a rate of 10 K per hour. 
Refinement
H atoms were positioned geometrically and refined as riding atoms with C-H = 0.93 and N-H = 0.86 Å, U iso (H) = 1.2U eq (C,N).
Computing details
Data collection: SMART (Bruker, 2007 ); cell refinement: SAINT (Bruker, 2007) ; data reduction: SAINT (Bruker, 2007 SHELXTL (Sheldrick, 2008) .
Figure 1
The asymmetric unit of the title compound. Displacement ellipsoids are drawn at the 30% probability level.
Figure 2
Perspective view of the chains in the title compound.
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Figure 3
Crystal packing of the title compound. Dashed lines denote hydrogen bonds.
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